BBVA USA Bancshares’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.96M Buy
39,629
+1,510
+4% +$72.5K 0.09% 209
2020
Q4
$1.85M Buy
38,119
+1,159
+3% +$57.2K 0.1% 194
2020
Q3
$1.86M Buy
36,960
+2,976
+9% +$153K 0.11% 173
2020
Q2
$1.74M Buy
33,984
+7,135
+27% +$347K 0.1% 173
2020
Q1
$1.17M Buy
26,849
+25,910
+2,759% +$1.24M 0.08% 197
2019
Q4
$47K Buy
+939
New +$44K ﹤0.01% 544

Other funds holding SNY

BBVA USA Bancshares's SNY Position: Q1 2021 in Review

BBVA USA Bancshares increased its Sanofi (SNY) stake by 4% in Q1 2021, buying an estimated $72.5K and bringing the position to 39,629 shares worth $1.96M. The position accounts for 0.09% of the portfolio, ranked #209.

BBVA USA Bancshares first reported a position in SNY in Q4 2019 and has held it in 6 quarters since. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • BBVA USA Bancshares held 39,629 shares of Sanofi worth $1.96M as of Q1 2021.
  • BBVA USA Bancshares bought 1,510 Sanofi shares in Q1 2021, an estimated $72.5K.
  • Sanofi made up 0.09% of BBVA USA Bancshares's portfolio in Q1 2021, its #209 holding.
  • BBVA USA Bancshares first reported a position in Sanofi in Q4 2019 and has held it in 6 quarters since.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.